743 related articles for article (PubMed ID: 15249058)
21. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
Bedenic B; Vranes J; Suto S; Zagar Z
Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
[TBL] [Abstract][Full Text] [Related]
22. Tigecycline: in-vitro performance as a predictor of clinical efficacy.
Hawkey P; Finch R
Clin Microbiol Infect; 2007 Apr; 13(4):354-62. PubMed ID: 17359318
[TBL] [Abstract][Full Text] [Related]
23. Risks of extended-spectrum beta-lactamases.
BMJ Group
Drug Ther Bull; 2008 Mar; 46(3):21-4. PubMed ID: 18337463
[TBL] [Abstract][Full Text] [Related]
24. [Extended-spectrum beta-lactamases: their role in clinical microbiology laboratory, treatment and infection control].
Dolapçi I
Mikrobiyol Bul; 2005 Apr; 39(2):229-40. PubMed ID: 16128036
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients.
Men TY; Wang JN; Li H; Gu Y; Xing TH; Peng ZH; Zhong L
Transpl Infect Dis; 2013 Feb; 15(1):14-21. PubMed ID: 23013385
[TBL] [Abstract][Full Text] [Related]
26. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
Bedenić B
Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
[TBL] [Abstract][Full Text] [Related]
27. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
Dudley M
Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
[TBL] [Abstract][Full Text] [Related]
28. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
30. Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
Sekowska A; Janicka G; Kłyszejko C; Wojda M; Wróblewski M; Szymankiewicz M
Med Sci Monit; 2002 Mar; 8(3):BR100-4. PubMed ID: 11889457
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
[TBL] [Abstract][Full Text] [Related]
32. Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).
Szabó D; Barcs I; Rozgonyi F
Acta Microbiol Immunol Hung; 1997; 44(4):309-25. PubMed ID: 9554165
[TBL] [Abstract][Full Text] [Related]
33. Extended spectrum beta-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience.
Zaki Mel S
J Infect Dev Ctries; 2007 Dec; 1(3):269-74. PubMed ID: 19734604
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
[TBL] [Abstract][Full Text] [Related]
35. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China.
Yu Y; Ji S; Chen Y; Zhou W; Wei Z; Li L; Ma Y
J Infect; 2007 Jan; 54(1):53-7. PubMed ID: 16533535
[TBL] [Abstract][Full Text] [Related]
36. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.
Pfaller MA; Segreti J
Clin Infect Dis; 2006 Apr; 42 Suppl 4():S153-63. PubMed ID: 16544266
[TBL] [Abstract][Full Text] [Related]
37. What's new in antibiotic resistance? Focus on beta-lactamases.
Babic M; Hujer AM; Bonomo RA
Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of extended-spectrum beta-lactamases (ESBLs) produced in blood isolates of gram-negative bacteria in a teaching hospital in southern Thailand.
Jitsurong S; Yodsawat J
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):131-5. PubMed ID: 16771225
[TBL] [Abstract][Full Text] [Related]
39. [Drug-resistance analysis of Gram-negative bacilli producing extended-spectrum beta-lactamases in lower respiratory tract infection].
Long J; Lü SC
Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):439-40, 444. PubMed ID: 15090319
[TBL] [Abstract][Full Text] [Related]
40. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
